ALB and metabolic syndrome: As demonstrated in Cavero-Redondo et al. [10], we validated our score by using it to predict vascular damage (associated with MetS) according to the albumin-to-creatinine ratio (e.g., ACR \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\ge 30 mg/g$$\end{document}≥30mg/g), a typical, though not alone sufficient, metric of clinical performance for a MetS score [52, 56, 57].